Early Initiation of Interferon Beta-1b after a First Clinical Event Suggestive of Multiple Sclerosis: Clinical Outcomes and Use of Disease-Modifying Therapy from the BENEFIT Extension Study (PD5.002)
暂无分享,去创建一个
F. Barkhof | X. Montalban | L. Kappos | C. Polman | H. Hartung | D. Miller | M. Freedman | G. Edan | C. Pohl | B. Stemper | R. Sandbrink | D. Pleimes | V. Lanius